⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6843553 | 1.00 | — | — | |
| SCHEMBL12777784 | 0.83 | — | — | |
| SCHEMBL1003675 | 0.83 | — | — | |
| SCHEMBL2074979 | 0.75 | MAPK1 (0.35) | — | |
| SCHEMBL2074977 | 0.75 | MAPK1 (0.35) | — | |
| SCHEMBL4100162 | 0.73 | MEN1 (0.35) | — | |
| SCHEMBL15692308 | 0.73 | CRBN (0.38) | — | |
| SCHEMBL21570650 | 0.73 | — | — | |
| SCHEMBL16666800 | 0.73 | MEN1 (0.35) | — | |
| SCHEMBL10232389 | 0.73 | CRBN (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6548502-B2 | Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives | PFIZER INC | 2003-04-15 | — | — | US | disclosed |
| US-20020049209-A1 | Dopamine D4 ligands for the treatment of novelty-seeking disorders | PFIZER INC. | 2002-04-25 | — | — | US | disclosed |